用于免疫疾病临床试验的间充质干细胞 - Suppr

Suppr

超能文献

Mesenchymal Stem Cells in Clinical Trials for Immune Disorders.

作者信息

Li Zongjin, Han Zhibo, Han Zhong-Chao

机构信息

Department of Pathophysiology, Nankai University School of Medicine, Tianjin, China.

Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.

出版信息

Glob Med Genet. 2024 Jun 27;11(3):196-199. doi: 10.1055/s-0044-1788044. eCollection 2024 Sep.

DOI:10.1055/s-0044-1788044

PMID:38947762

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11210999/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87db/11210999/17ec496d950e/10-1055-s-0044-1788044-i2400045-1.jpg

相似文献

Mesenchymal Stem Cells in Clinical Trials for Immune Disorders.用于免疫疾病临床试验的间充质干细胞

Glob Med Genet. 2024 Jun 27;11(3):196-199. doi: 10.1055/s-0044-1788044. eCollection 2024 Sep.

Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review.评估间充质干细胞治疗移植物抗宿主病的临床试验现状：系统评价。

Stem Cell Res Ther. 2022 Mar 4;13(1):93. doi: 10.1186/s13287-022-02751-0.

Efficacy and safety of mesenchymal stem cell therapy in acute on chronic liver failure: a systematic review and meta-analysis of randomized controlled clinical trials.间充质干细胞疗法治疗慢加急性肝衰竭的疗效与安全性：随机对照临床试验的系统评价与荟萃分析

Stem Cell Res Ther. 2025 Apr 20;16(1):197. doi: 10.1186/s13287-025-04303-8.

Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials.间充质干细胞治疗 COVID-19 患者的疗效和安全性：随机对照试验的系统评价和荟萃分析。

J Transl Med. 2024 Jun 8;22(1):550. doi: 10.1186/s12967-024-05358-6.

Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.动物博来霉素肺纤维化模型中的间充质基质细胞：一项系统综述。

Stem Cells Transl Med. 2015 Dec;4(12):1500-10. doi: 10.5966/sctm.2015-0121. Epub 2015 Oct 22.

Therapeutic Potential of Adipose Mesenchymal Stem Cells for Synovial Regeneration: from In-Vitro Studies to Clinical Applications.脂肪间充质干细胞用于滑膜再生的治疗潜力：从体外研究到临床应用

Stem Cell Rev Rep. 2025 Jun 10. doi: 10.1007/s12015-025-10909-5.

A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn's Disease: Progress Made and Future Directions.系统评价和荟萃分析：间充质干细胞注射治疗肛周克罗恩病：进展与未来方向。

Dis Colon Rectum. 2018 May;61(5):629-640. doi: 10.1097/DCR.0000000000001093.

Safety and immune regulatory properties of canine induced pluripotent stem cell-derived mesenchymal stem cells.犬诱导多能干细胞来源的间充质干细胞的安全性及免疫调节特性

Stem Cell Res. 2017 Dec;25:221-232. doi: 10.1016/j.scr.2017.11.010. Epub 2017 Nov 14.

Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells.间充质干细胞治疗肾脏疾病的研究进展。

Curr Pharm Des. 2024;30(11):825-840. doi: 10.2174/0113816128296105240305110312.

Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis.研究造血和间充质干细胞移植治疗 T1DM 的安全性和有效性：系统评价和荟萃分析。

Syst Rev. 2022 May 2;11(1):82. doi: 10.1186/s13643-022-01950-3.

引用本文的文献

Pathological mechanisms and treatment progression of Alzheimer's disease.阿尔茨海默病的病理机制与治疗进展

Eur J Med Res. 2025 Jul 14;30(1):625. doi: 10.1186/s40001-025-02886-9.

Extracellular vesicles derived from mesenchymal stem cells alleviate renal fibrosis via the miR-99b-5p/mTOR/autophagy axis in diabetic kidney disease.间充质干细胞衍生的细胞外囊泡通过miR-99b-5p/mTOR/自噬轴减轻糖尿病肾病中的肾纤维化。

Stem Cell Res Ther. 2025 Mar 18;16(1):142. doi: 10.1186/s13287-025-04265-x.

Potential Mechanism and Perspectives of Mesenchymal Stem Cell Therapy for Ischemic Stroke: A Review.间充质干细胞治疗缺血性中风的潜在机制与前景：综述

Glob Med Genet. 2024 Sep 2;11(4):278-284. doi: 10.1055/s-0044-1790231. eCollection 2024 Dec.

本文引用的文献

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial.人脐带间充质干细胞治疗难治性免疫性血小板减少症的疗效与安全性：一项前瞻性、单臂、I期试验

Signal Transduct Target Ther. 2024 Apr 23;9(1):102. doi: 10.1038/s41392-024-01793-5.

Therapeutic trends of priming mesenchymal stem cells: A bibliometric analysis.间充质干细胞预处理的治疗趋势：一项文献计量分析。

Biochem Biophys Rep. 2024 Apr 8;38:101708. doi: 10.1016/j.bbrep.2024.101708. eCollection 2024 Jul.

Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.间充质干细胞的免疫调节机制及其潜在的临床应用。

Int J Mol Sci. 2022 Sep 2;23(17):10023. doi: 10.3390/ijms231710023.

Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection.静脉内移植的间充质基质细胞：心脏保护的新内分泌储库。

Stem Cell Res Ther. 2022 Jun 17;13(1):253. doi: 10.1186/s13287-022-02922-z.

Stem cell translational medicine: The Tianjin model revisited.干细胞转化医学：天津模式再探讨。

Stem Cells Transl Med. 2021 Nov;10 Suppl 2(Suppl 2):S4-S9. doi: 10.1002/sctm.20-0494.

Development and investigational new drug application of mesenchymal stem/stromal cells products in China.中国间充质干细胞/基质细胞产品的研发和新药临床试验申请。

Stem Cells Transl Med. 2021 Nov;10 Suppl 2(Suppl 2):S18-S30. doi: 10.1002/sctm.21-0083.

Successful Treatment of a 19-Month-Old Boy with Hepatitis Associated Aplastic Anemia by Infusion of Umbilical Cord-Derived Mesenchymal Stromal Cells: A Case Report.脐带间充质干细胞输注治疗 19 月龄肝炎相关性再生障碍性贫血患儿 1 例报告

Cell Transplant. 2021 Jan-Dec;30:963689720977144. doi: 10.1177/0963689720977144.

Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines.间质干细胞在肿瘤生长中的双刃剑作用：聚焦 MSC 衍生细胞因子。

Cell Mol Biol Lett. 2021 Jan 20;26(1):3. doi: 10.1186/s11658-020-00246-5.

IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE-mediated M2 macrophage polarization.IGF-1C 水凝胶通过 PGE 介导的 M2 巨噬细胞极化增强 MSC 对结肠炎的治疗作用。

Theranostics. 2020 Jun 19;10(17):7697-7709. doi: 10.7150/thno.45434. eCollection 2020.

New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types.细胞治疗的新范式：重复给药、静脉给药、免疫调节作用和新型细胞类型。

Circ Res. 2018 Jul 6;123(2):138-158. doi: 10.1161/CIRCRESAHA.118.313251.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验